Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) EBT (2021 - 2025)

Historic EBT for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$2.4 million.

  • HeartSciences' EBT fell 1190.44% to -$2.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$9.1 million, marking a year-over-year decrease of 1701.1%. This contributed to the annual value of -$8.9 million for FY2025, which is 3293.13% down from last year.
  • HeartSciences' EBT amounted to -$2.4 million in Q4 2025, which was down 1190.44% from -$2.1 million recorded in Q3 2025.
  • In the past 5 years, HeartSciences' EBT registered a high of -$752051.0 during Q3 2021, and its lowest value of -$2.6 million during Q1 2025.
  • For the 5-year period, HeartSciences' EBT averaged around -$1.7 million, with its median value being -$1.8 million (2022).
  • Per our database at Business Quant, HeartSciences' EBT plummeted by 10925.5% in 2022 and then surged by 2054.79% in 2023.
  • Quarter analysis of 5 years shows HeartSciences' EBT stood at -$1.0 million in 2021, then tumbled by 74.7% to -$1.8 million in 2022, then grew by 3.28% to -$1.7 million in 2023, then fell by 20.26% to -$2.1 million in 2024, then decreased by 11.9% to -$2.4 million in 2025.
  • Its EBT stands at -$2.4 million for Q4 2025, versus -$2.1 million for Q3 2025 and -$2.1 million for Q2 2025.